Some biosimilars are just as good as some pricey biologics

A new study suggests that a group of biosimilar drugs, which are used to treat such afflictions as rheumatoid arthritis, psoriasis, and inflammatory bowel disease, appear as safe and effective… The post Some biosimilars are just as good as some pricey biologics appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Biotechblog